Trulieve Cannabis Corp. Subordinate Voting Shares

As of June 30, 2026, Trulieve Cannabis Corp. carries a market capitalization of 1.96B, placing it among publicly traded companies globally. Its enterprise value stands at 2.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Trulieve Cannabis Corp.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Trulieve Cannabis Corp. has 192.38M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.96, and the price-to-book ratio stands at 2.91.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.18 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.17B versus a market cap of 1.96B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Trulieve Cannabis Corp. maintains a current ratio of 5.94, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 75.37, indicating elevated leverage, while an interest coverage ratio of -1.89 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. posted a negative return on equity (ROE) of -47.51, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.93, reflecting losses generated across the asset base. The company generates approximately 189,905.09 in revenue per employee across its workforce of 5,250.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.16 indicates how many times Trulieve Cannabis Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. recorded 126.70M in income tax expense. The company reported a pretax loss of -285.29M and -414.28M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 11, 2026, Trulieve Cannabis Corp.'s stock has gained approximately 14.87% over the past 52 weeks. The 50-day moving average sits at 7.48, while the 200-day moving average is 6.47.

Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. generated 997.00M in revenue and converted that into -414.28M in net income, yielding earnings per share of -2.13. EBITDA reached -93.93M, while operating income came in at 114.72M.

As of June 30, 2026, Trulieve Cannabis Corp. holds 284.84M in cash and equivalents against 505.28M in total debt, resulting in a net debt position of -31.54M. Total book value stands at 671.76M, with working capital of 411.19M providing operational flexibility.

Trulieve Cannabis Corp. produced 213.96M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -20.57M in capital expenditures, free cash flow totaled 193.39M - equivalent to 1.01 per share.

Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. posted a gross margin of 59.47, reflecting its pricing power and cost economics. The operating margin of 11.51 and net profit margin of -41.55 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 9.84, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 9.45, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Trulieve Cannabis Corp. shareholders.

As of June 30, 2026, Trulieve Cannabis Corp. has an Altman Z-Score of 1.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.